| Feasibility Study of Transcranial Ultrasound Stimulation on Alzheimer's Disease Patients (NCT03896698) | National Yang Ming Chiao Tung University | 2019-08-23 |
| Treating Hyperexcitability in AD With Levetiracetam (NCT03875638) | Beth Israel Deaconess Medical Center | 2019-08-22 |
| Daily Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease (NCT04055376) | Massachusetts Institute of Technology | 2019-08-14 |
| Gamma Induction for Alzheimer's Disease (NCT03880240) | Massachusetts General Hospital | 2019-08-05 |
| ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease (NCT03622905) | Functional Neuromodulation Ltd | 2019-08-01 |
| Phase1a, Dose-escalation Study of NNI-362 in Healthy Aged Volunteers (NCT04074837) | Neuronascent, Inc. | 2019-08-01 |
| Grounding Effect on Alzheimer's Disease (NCT05246332) | Chang Gung Memorial Hospital | 2019-08-01 |
| Heidelberg In Vivo Confocal Microscopy to Evaluate the Ocular Surface Disorders of Healthy and Diseased Individuals (NCT04025801) | National Taiwan University Hospital | 2019-07-31 |
| Decreased Empathy and Emotion Recognition in Patients With Neurodegenerative Disease (NCT04635540) | University Health Network, Toronto | 2019-07-22 |
| A Lexico-semantic Program on Tactile Tablet for Patients With Alzheimer's Disease (NCT03047694) | Assistance Publique - Hôpitaux de Paris | 2019-07-15 |
| The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition (NCT04082611) | Saint John's Cancer Institute | 2019-07-12 |
| A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease (NCT04031469) | ProgenaBiome | 2019-07-11 |
| CUHK Brain Health Longitudinal Study (NCT03592563) | Chinese University of Hong Kong | 2019-07-01 |
| A Study to Evaluate the Efficacy and Safety of Brain Polypeptide Solution in Mild Alzheimer's Disease (NCT03978338) | Peking Union Medical College Hospital | 2019-07-01 |
| Reversal of Cognitive Decline (ReCODE) Study (NCT03883633) | QuesGen Systems Inc | 2019-06-30 |
| Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease (NCT03821857) | Mayo Clinic | 2019-06-27 |
| Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance (NCT03980730) | vTv Therapeutics | 2019-06-27 |
| Neuro RX Gamma - Pivotal Phase (NCT03484143) | Vielight Inc. | 2019-06-26 |
| Computerized Olfactory Test - Alzheimer Disease Mild Stage (NCT03698760) | Jewish General Hospital | 2019-06-25 |
| Low Dose IL2 Immunotherapy in AD (NCT05821153) | The Methodist Hospital Research Institute | 2019-06-19 |
| Tau Imaging With JNJ067 (NCT03926702) | University of California, Berkeley | 2019-06-18 |
| Comparisons of gaIt aNalyses pERformance Between the Gaitrite walkwaYs (NCT04557592) | University Hospital, Angers | 2019-06-17 |
| The Effect of High Fat Diet on the Pharmacokinetics of AD16 Tablets in Healthy Chinese Adult Subjects (NCT05787041) | South China Center For Innovative Pharmaceuticals | 2019-06-14 |
| Effects of Visual Cues and Education for People Who Live Within Long Term Care Communities to Assist in Wayfinding (NCT03537729) | Grand Valley State University | 2019-06-12 |
| Alzheimer Biomarkers on CSF of Elderly Patients Undergoing Surgery (NCT03977025) | University of Chile | 2019-06-11 |
| Tau Positron Emission Tomography (PET) Longitudinal Substudy Associated With: Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers in the Treatment of Autosomal-Dominant Alzheimer's Disease (NCT03977584) | Hoffmann-La Roche | 2019-06-10 |
| Neurofeedback in Alzheimer's Disease (NCT03790774) | Oregon Health and Science University | 2019-06-06 |
| HAPPCAP-AD (Human-APPlication Combined Approach for Prevention of Alzheimer's Disease) (NCT05256121) | Sheba Medical Center | 2019-06-04 |
| TRC-PAD Program: In-Clinic Trial-Ready Cohort (NCT04004767) | University of Southern California | 2019-06-04 |
| Physical Activity, Alzheimer's Disease and Cognition Relative to APOE Genotype (NCT03876314) | University of North Carolina, Greensboro | 2019-05-23 |
| Vestibular Physical Therapy for People With Alzheimer Disease (NCT03887923) | University of Pittsburgh | 2019-05-10 |
| Auburn University Research on Olive Oil for Alzheimer's Disease (AU-ROOAD) (NCT03824197) | Auburn University | 2019-05-07 |
| PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION (NCT03999879) | NYU Langone Health | 2019-05-01 |
| Autoimmune Features of Neurodegenerative Disorders (NCT04239079) | Columbia University | 2019-05-01 |
| INTERCEPTOR Project: From MCI to Dementia (NCT03834402) | Catholic University of the Sacred Heart | 2019-05-01 |
| Utilizing Senior Companions to Enhance Dementia Care (NCT03667924) | University of Minnesota | 2019-04-29 |
| Cohort Study of Adult Patients With Down Syndrome at Risk of Developing Alzheimer's Disease (TriAL21) (NCT03901261) | Institut Jerome Lejeune | 2019-04-26 |
| Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS (NCT03846492) | Centre for Addiction and Mental Health | 2019-04-24 |
| High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease (NCT04042922) | Massachusetts Institute of Technology | 2019-04-19 |
| Transcranial Electromagnetic Treatment Against Alzheimer's Disease (NCT03927040) | NeuroEM Therapeutics, Inc. | 2019-04-15 |
| Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease (NCT03903211) | Jae Seung Kim | 2019-04-09 |
| Study to Evaluate Amyloid in Blood and Imaging Related to Dementia (NCT03899844) | Washington University School of Medicine | 2019-04-09 |
| Multimodal Imaging Study on Physical Activity in Patients With Alzheimer's Disease (NCT03939286) | RWTH Aachen University | 2019-04-08 |
| Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint. (NCT03863041) | Poitiers University Hospital | 2019-04-08 |
| A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking (NCT03919669) | University of Wisconsin, Madison | 2019-04-02 |
| Non-pharmacological Intervention for Preclinical Alzheimer's Disease (NCT04279418) | XuanwuH 2 | 2019-04-01 |
| A Four Month Home Based tDCS Study on Patients With Alzheimer's Disease. (NCT04759092) | University Hospital of North Norway | 2019-04-01 |
| Neurofeedback Intervention for Preclinical Alzheimer's Disease (NCT04300933) | XuanwuH 2 | 2019-04-01 |
| The Safety and Scientific Validity of Low-dose Whole Brain Radiotherapy in Alzheimer's Disease. (NCT04203121) | Kyung Hee University Hospital at Gangdong | 2019-04-01 |
| First in Human Study for Safety and Tolerability of AL003. (NCT03822208) | Alector Inc. | 2019-03-29 |
| Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease (NCT03901105) | Avid Radiopharmaceuticals | 2019-03-28 |
| GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease (NCT03823404) | Cortexyme Inc. | 2019-03-28 |
| Movement Intervention for Memory Enhancement (NCT03475316) | Albert Einstein College of Medicine | 2019-03-28 |
| A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation (NCT03901092) | Avid Radiopharmaceuticals | 2019-03-26 |
| Alzheimer's PET Imaging in Racially/Ethnically Diverse Adults (NCT03706261) | Adam Brickman | 2019-03-22 |
| Blood Biomarkers from Internal Jugular Vein for the Diagnosis of Alzheimer's Disease (NCT06754254) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2019-03-21 |
| Network-based rTMS in Alzheimer's Disease (NCT04263194) | IRCCS Centro San Giovanni di Dio Fatebenefratelli | 2019-03-21 |
| The Music, Sleep and Dementia Study (NCT04157244) | University of Pennsylvania | 2019-03-12 |
| Falls: A Marker of Preclinical AD (NCT04949529) | Washington University School of Medicine | 2019-03-07 |
| PTI-125 for Mild-to-moderate Alzheimer's Disease Patients (NCT03748706) | Pain Therapeutics | 2019-03-07 |
| Nutrition Interventions for Cognitive Enhancement (NCT03841539) | University of Kansas Medical Center | 2019-03-07 |
| Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease (NCT03810794) | Jian Pei,MD | 2019-03-01 |
| Study to Evaluate DNL747 in Subjects With Alzheimer's Disease (NCT03757325) | Denali Therapeutics Inc. | 2019-02-13 |
| Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides (NCT03635879) | Cerecin | 2019-02-13 |
| Detection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance Imaging (NCT03846232) | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 2019-02-12 |
| The Efficacy of Traditional Chinese Herbal Medicine for Dementia (NCT03838952) | Taipei Veterans General Hospital, Taiwan | 2019-02-11 |
| Mindfulness for Alzheimer Caregivers (NCT03858283) | Universidad Miguel Hernandez de Elche | 2019-02-02 |
| Investigating the Impact of Alzheimer's Disease Diagnostics in British Columbia (NCT05002699) | University of British Columbia | 2019-02-01 |
| Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease (NCT03703856) | University of California, San Diego | 2019-01-31 |
| Dapagliflozin In Alzheimer's Disease (NCT03801642) | Jeff Burns, MD | 2019-01-29 |
| Validation of a Smartphone Application for the Assessment of Patients With Mild Cognitive Impairment: MemScreen (NCT03811184) | MemScreen | 2019-01-17 |
| Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study (NCT04080544) | Neil M Rofsky, MD, MHA | 2019-01-15 |
| The Cognition and Flow Study (NCT03656107) | University of Leicester | 2019-01-14 |
| U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (NCT03688126) | Wake Forest University Health Sciences | 2019-01-08 |
| Multimodal Ocular Imaging in Neurodegeneration (NCT03699644) | University of Michigan | 2019-01-04 |
| Noradrenergic Add-on Therapy With Guanfacine (NCT03116126) | Imperial College London | 2019-01-04 |
| Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2 (NCT03933696) | Icahn School of Medicine at Mount Sinai | 2019-01-02 |
| Biomarker-based Alzheimer's Disease Cohort Study (BASIC) (NCT07109999) | Xuanwu Hospital, Beijing | 2019-01-01 |
| Developing Advanced Blood-Brain Barrier Permeability Imaging for Early AD (NCT03389698) | NYU Langone Health | 2018-12-18 |
| Cognitive Decline in AD (NCT03946930) | Chinese University of Hong Kong | 2018-12-13 |
| The Relationship Between Neuropsychological Testing and MRI, PET and COBRE - Project 1: AIM 2 (GE-180) (NCT03702816) | Aaron Ritter, MD | 2018-12-13 |
| MAD Phase I Study to Investigate Contraloid Acetate (NCT03955380) | Prof. Dr. Dieter Willbold | 2018-12-12 |
| Accompanying ALZHEIMER CAREGIVER (NCT03994237) | University Hospital, Bordeaux | 2018-12-12 |
| Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD (NCT03819699) | H. Lundbeck A/S | 2018-12-12 |
| ExAblate Blood-Brain Barrier Opening for Treatment of Alzheimer's Disease (NCT03739905) | InSightec | 2018-12-06 |
| Innovations in Dementia Empowerment and Action (NCT03550131) | University of Washington | 2018-12-05 |
| Enhanced Quality in Primary Care for Elders With Diabetes and Dementia (NCT03723707) | NYU Langone Health | 2018-12-03 |
| Brain Energy Metabolism and Sleep in Adults (NCT03929302) | The University of Texas at Dallas | 2018-11-30 |
| Using Exercise and Electrical Brain Stimulation to Improve Memory in Dementia (NCT03670615) | Sunnybrook Health Sciences Centre | 2018-11-28 |
| The Sleep Amyloid, Slow WAve Race and Ethnicity Study (NCT03814603) | NYU Langone Health | 2018-11-21 |
| Light and the Effect on Metabolic Syndrome and Alzheimer's Disease (NCT03777722) | Icahn School of Medicine at Mount Sinai | 2018-11-19 |
| The Synapse Project (NCT04871074) | University of Wisconsin, Madison | 2018-11-18 |
| Stimulating Neural Activity to Improve Blood Flow and Reduce Amyloid: Path to Clinical Trials (NCT03543878) | Emory University | 2018-11-16 |
| A Phase I Study for Safety and Tolerability of AL002. (NCT03635047) | Alector Inc. | 2018-11-12 |
| Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type (NCT03721705) | Renew Research, LLC | 2018-11-12 |
| Deep Brain Stimulation with LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease (NCT03347084) | University of California, Los Angeles | 2018-11-10 |
| A Study of LY3372993 in Healthy Participants and Participants With Alzheimer's Disease (AD) (NCT03720548) | Eli Lilly and Company | 2018-11-05 |
| An Investigation of Levetiracetam in Alzheimer's Disease (NCT03489044) | University of Oxford | 2018-10-28 |
| Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study (NCT03724136) | MD Stem Cells | 2018-10-24 |
| Deep TMS for Comorbid Depression and Cognitive Impairment in Older Adults (NCT03665831) | Rotman Research Institute at Baycrest | 2018-10-23 |